Synergistic Amplification Mechanism When combined, CJC-1295 (NO DAC) and ipamorelin blend peptide create a complementary effect through activation of distinct receptor families: CJC-1295 amplifies the frequency and baseline of growth hormone pulses via GHRH receptor stimulation Ipamorelin increases the amplitude (peak height) of growth hormone pulses via ghrelin receptor activation Combined administration results in 3- to 5-fold greater growth hormone release compared to either peptide alone Maintenance of natural pulsatile secretion pattern prevents receptor desensitization The mechanism involves cooperative signaling through the cyclic AMP (cAMP) and phospholipase C pathways, with GHRH receptor activation increasing intracellular cAMP levels while ghrelin receptor activation potentiates calcium mobilization in somatotroph cells
Take the quiz Skin Type: All skin types Skin Type: + All skin types Concern: Anti-Aging, Brown spots, Dull skin Ingredients: Vitamin C, Glutathione, Ergothioneine View all Routine: Treatment How does it work
The most dangerous outcome can be hypoglycemic coma, when the brain is deprived of glucose and oxygen, and can be fatal
Therapeutic Research Protocol Dose: 2 mg Tesamorelin + 300 mcg Ipamorelin Duration: 12 16 weeks Frequency: Daily, evening administration Cycle Interval: 6 8 weeks off before repeating Goal / Description: Higher-dose protocol for visceral fat reduction and IGF-1 elevation studies
However, natural IGF-1 has a glaring limitation: its lifespan in the body is incredibly short, and it is easily neutralized by binding proteins that prevent it from doing its job effectively
